Connect your AI

Teladoc Health TDOC Proceeds from issuance of common stock relating to employee stock plans

Proceeds from issuance of common stock relating to employee stock plans at other companies

DoximityDOCS

——

Other financials

Income statement

Revenue$613.8M-2.5%

Gross profit$416.3M-3.8%

Operating income-$61.8M+48.8%

Net income-$63.8M+31.4%

EPS (diluted)-$0.36+32.1%

Balance sheet

Cash & equivalents$750.7M-37.1%

Total debt$42.2M-92.9%

Total equity$1.3B-6.4%

Total assets$2.8B-18.5%

Cash flow

Operating cash flow$9.5M-40.2%

CapEx$1.7M-39.1%

Free cash flow$7.9M-40.5%

Valuation

Market cap$1.41B+16.5%

Enterprise value$701.31M+14.7%

P/S0.6×+0.1×

Profitability

Gross margin69.3%-1.2pp

Operating margin-8.1%-3.6pp

Net margin-6.8%-3.1pp

FCF margin11.1%-0.2pp

Returns & leverage

Return on equity-12.4%-5.4pp

Debt / equity0×-0.4×

Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's proceeds from issuance of common stock relating to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Teladoc Health's proceeds from issuance of common stock relating to employee stock plans?: Teladoc Health (TDOC) reported proceeds from issuance of common stock relating to employee stock plans of $399K in Q1 2026.
How has Teladoc Health's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?: Teladoc Health's proceeds from issuance of common stock relating to employee stock plans decreased by 42.1% year-over-year, from $689K to $399K.